ZimVie Inc. (NASDAQ:ZIMV) Shares Acquired by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lifted its position in ZimVie Inc. (NASDAQ:ZIMV) by 3.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 102,431 shares of the company’s stock after purchasing an additional 3,441 shares during the period. Massachusetts Financial Services Co. MA owned about 0.37% of ZimVie worth $1,869,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Cetera Advisors LLC acquired a new position in shares of ZimVie in the first quarter worth about $2,615,000. CenterBook Partners LP purchased a new position in ZimVie during the fourth quarter worth approximately $988,000. Gabelli Funds LLC grew its holdings in ZimVie by 25.4% in the fourth quarter. Gabelli Funds LLC now owns 40,260 shares of the company’s stock valued at $715,000 after purchasing an additional 8,160 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of ZimVie by 6.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,531 shares of the company’s stock worth $356,000 after buying an additional 1,275 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of ZimVie by 21.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 761,285 shares of the company’s stock worth $13,513,000 after buying an additional 132,804 shares during the period. 95.63% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Needham & Company LLC boosted their price target on shares of ZimVie from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Friday, August 2nd.

ZimVie Price Performance

NASDAQ:ZIMV opened at $16.55 on Monday. The stock has a 50 day moving average of $18.14 and a two-hundred day moving average of $17.17. ZimVie Inc. has a 12 month low of $6.52 and a 12 month high of $22.40. The firm has a market cap of $451.63 million, a P/E ratio of -1.19 and a beta of 2.13. The company has a current ratio of 1.94, a quick ratio of 1.43 and a debt-to-equity ratio of 0.62.

ZimVie (NASDAQ:ZIMV) last announced its quarterly earnings data on Thursday, August 1st. The company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.04). ZimVie had a negative net margin of 63.84% and a positive return on equity of 2.21%. The firm had revenue of $116.81 million during the quarter. During the same quarter in the prior year, the firm earned $0.17 EPS. On average, analysts expect that ZimVie Inc. will post 0.63 earnings per share for the current fiscal year.

Insider Buying and Selling

In other ZimVie news, major shareholder Camber Capital Management Lp sold 525,000 shares of the stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $17.71, for a total value of $9,297,750.00. Following the completion of the sale, the insider now owns 2,725,000 shares in the company, valued at approximately $48,259,750. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 3.01% of the stock is currently owned by company insiders.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.